Research Paper Volume 13, Issue 7 pp 9398—9418

A novel oral nutritional supplement improves gait speed and mitochondrial functioning compared to standard care in older adults with (or at risk of) undernutrition: results from a randomized controlled trial

(A) Change in lean mass and fat mass over the course of the intervention period in the two treatment groups. ***, significant increase in fat mass within both groups between week 0 and 6; **, significant increase in fat mass within the standard supplement group between week 6 and 12; *, significant increase in lean mass between week 0 and 6 in the standard supplement group. (B) proportion of fat mass (79.5% in novel supplement, 87.7% in standard supplement) and (appendicular) lean mass (20.5% in novel supplement, 12.2% in standard supplement) as part of the total weight gain in the two groups.

Figure 2. (A) Change in lean mass and fat mass over the course of the intervention period in the two treatment groups. ***, significant increase in fat mass within both groups between week 0 and 6; **, significant increase in fat mass within the standard supplement group between week 6 and 12; *, significant increase in lean mass between week 0 and 6 in the standard supplement group. (B) proportion of fat mass (79.5% in novel supplement, 87.7% in standard supplement) and (appendicular) lean mass (20.5% in novel supplement, 12.2% in standard supplement) as part of the total weight gain in the two groups.